KLHL7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.878000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.856200E-01
Normal-vs-Stage2
8.799600E-01
Normal-vs-Stage3
5.559000E-01
Normal-vs-Stage4
2.186000E-01
Stage1-vs-Stage2
5.022000E-01
Stage1-vs-Stage3
7.022800E-01
Stage1-vs-Stage4
4.527900E-02
Stage2-vs-Stage3
3.842400E-01
Stage2-vs-Stage4
2.537000E-01
Stage3-vs-Stage4
6.142300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.221200E-01
Normal-vs-AfricanAmerican
9.982000E-01
Normal-vs-Asian
8.061800E-01
Caucasian-vs-AfricanAmerican
8.932600E-01
Caucasian-vs-Asian
6.970600E-01
AfricanAmerican-vs-Asian
7.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.871600E-01
Normal-vs-Female
7.265000E-01
Male-vs-Female
1.594760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.890200E-01
Normal-vs-Age(41-60Yrs)
3.590400E-01
Normal-vs-Age(61-80Yrs)
8.664000E-01
Normal-vs-Age(81-100Yrs)
9.444600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.797000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.698200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.384400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.170000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.330970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.455800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.863800E-01
Normal-vs-Daily Drinker
6.567400E-01
Normal-vs-Weekly Drinker
7.385400E-01
Normal-vs-Occasional Drinker
4.800800E-01
Normal-vs-Social Drinker
6.868400E-01
Non Drinker-vs-Daily Drinker
6.771600E-01
Non Drinker-vs-Weekly Drinker
2.301000E-01
Non Drinker-vs-Occasional Drinker
4.528500E-02
Non Drinker-vs-Social Drinker
2.346200E-01
Daily Drinker-vs-Weekly Drinker
1.652990E-01
Daily Drinker-vs-Occasional Drinker
2.970000E-02
Daily Drinker-vs-Social Drinker
1.665030E-01
Weekly Drinker-vs-Occasional Drinker
6.606600E-01
Weekly Drinker-vs-Social Drinker
8.000000E-01
Occasional Drinker-vs-Social Drinker
9.351800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.836800E-01
Normal-vs-Grade 2
8.145800E-01
Normal-vs-Grade 3
7.869600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.768200E-01
Grade 1-vs-Grade 3
4.059200E-01
Grade 1-vs-Grade 4
6.836800E-01
Grade 2-vs-Grade 3
5.715000E-01
Grade 2-vs-Grade 4
8.145800E-01
Grade 3-vs-Grade 4
7.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.406000E-01
Normal-vs-NonDiabetic
8.574800E-01
Diabetic-vs-NonDiabetic
4.250000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.444200E-01
Normal-vs-NoPancreatitis
8.927800E-01
Pancreatitis-vs-NoPancreatitis
5.837400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.571400E-01
Normal-vs-N1
8.508400E-01
N0-vs-N1
6.344800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.199800E-01
Normal-vs-TP53-NonMutant
8.967200E-01
TP53-Mutant-vs-TP53-NonMutant
1.054960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
